Bank of America sees near-40% upside in medtech stock
Bank of America analysts see significant upside potential in Siemens Healthineers ahead of its full-year results on Feb. 5, as one healthcare investor pointed to the German medical technology group’s “compelling” product portfolio. BofA reiterated its Buy rating in a note this week, setting a 65 euro price target for the stock — a 38.4%…